Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia

Itai Levi; Pia Raanani; Bruria Shalmon; Regina Schiby-Brilliant; Isaac Ben-Bassat

doi:10.3109/10428199909050966

Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia

Itai Levi, Pia Raanani^*, Bruria Shalmon, Regina Schiby-Brilliant, Isaac Ben-Bassat

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticostcroids.

Original language	English
Pages (from-to)	401-404
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	34
Issue number	3-4
DOIs	https://doi.org/10.3109/10428199909050966
State	Published - 1999
Externally published	Yes

Keywords

APL
ATRA
Chemotherapy
Corticosteroids
Sweet's syndrome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428199909050966

Cite this

@article{e6e40c46d27e47f3a4174e49b6886967,

title = "Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia",

abstract = "All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticostcroids.",

keywords = "APL, ATRA, Chemotherapy, Corticosteroids, Sweet's syndrome",

author = "Itai Levi and Pia Raanani and Bruria Shalmon and Regina Schiby-Brilliant and Isaac Ben-Bassat",

year = "1999",

doi = "10.3109/10428199909050966",

language = "אנגלית",

volume = "34",

pages = "401--404",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3-4",

}

TY - JOUR

T1 - Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia

AU - Levi, Itai

AU - Raanani, Pia

AU - Shalmon, Bruria

AU - Schiby-Brilliant, Regina

AU - Ben-Bassat, Isaac

PY - 1999

Y1 - 1999

N2 - All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticostcroids.

AB - All-trans-retinoic acid (ATRA) is considered the recommended induction treatment for acute promyelocytic leukemia (APL). Although the dermatological side effects associated with ATRA treatment are relatively common, acute neutrophilic dermatosis (Sweet's syndrome) has only been rarely reported. We describe such a case who responded to chemotherapy and not to low doses of corticostcroids.

KW - APL

KW - ATRA

KW - Chemotherapy

KW - Corticosteroids

KW - Sweet's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032856637&partnerID=8YFLogxK

U2 - 10.3109/10428199909050966

DO - 10.3109/10428199909050966

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0032856637

SN - 1042-8194

VL - 34

SP - 401

EP - 404

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3-4

ER -

Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this